Pramipexole once-daily dosage form

Details for Australian Patent Application No. 2003256921 (hide)

Owner Pharmacia Corporation

Inventors Cox, Steven R.; Bredael, Gerard M.; Baldwin, John R.; Lee, Ernest J.; Heintz, Mark J.

Agent Spruson & Ferguson

Pub. Number AU-B-2003256921

PCT Number PCT/US03/23522

PCT Pub. Number WO2004/010999

Priority 60/398,427 25.07.02 US; 60/398,447 25.07.02 US; 60/479,514 18.06.03 US

Filing date 25 July 2003

Wipo publication date 16 February 2004

Acceptance publication date 5 March 2009

International Classifications

A61K 31/428 (2006.01) - condensed with carbocyclic rings

A61K 9/20 (2006.01) Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

A61K 9/28 (2006.01) Medicinal preparations characterised by special physical form - Dragees

A61K 9/36 (2006.01) Medicinal preparations characterised by special physical form

A61K 31/426 (2006.01) - 1,3-Thiazoles

A61K 31/4745 (2006.01)

A61P 25/16 (2006.01) Drugs for disorders of the nervous system

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

Event Publications

6 November 2003 Complete Application Filed

  Priority application(s): 60/398,427 25.07.02 US; 60/398,447 25.07.02 US; 60/479,514 18.06.03 US

25 March 2004 Application Open to Public Inspection

  Published as AU-B-2003256921

5 March 2009 Application Accepted

  Published as AU-B-2003256921

2 July 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003256922-SUBSTITUTED HETEROCYCLIC COMPOUNDS AS MODULATORS OF THE CCR5 RECEPTOR

2003256920-CARDIOVASCULAR HEALTH ENHANCEMENT WITH SOY FORTIFIED ORANGE JUICE COMPOSITIONS